MENU

LUMO Lumos Pharma Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company, which engages in the development of therapeutics for the treatment of Pediatric Growth Hormone Deficiency (PGHD)

Industry Biotechnology
LUMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
LUMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LUMO is expected to report earnings to fall 17.67% to -76 cents per share on November 14

Lumos Pharma LUMO Stock Earnings Reports
Q3'24
Est.
$-0.77
Q2'24
Beat
by $0.24
Q1'24
Missed
by $0.30
Q4'23
Missed
by $3.04
Q3'23
Beat
by $0.11
The last earnings report on August 01 showed earnings per share of -93 cents, beating the estimate of -116 cents. With 3.76K shares outstanding, the current market capitalization sits at 37.45M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of therapeutics for the treatment of Pediatric Growth Hormone Deficiency (PGHD)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 512 215-2630
Employees
33
Web
https://www.lumos-pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

LUMO and Stocks

Correlation & Price change

A.I.dvisor tells us that LUMO and BNOX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUMO and BNOX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUMO
1D Price
Change %
LUMO100%
+0.70%
BNOX - LUMO
28%
Poorly correlated
+8.20%
IKNA - LUMO
24%
Poorly correlated
-1.72%
CMRX - LUMO
22%
Poorly correlated
-5.40%
ATRA - LUMO
22%
Poorly correlated
-10.45%
BTAX - LUMO
22%
Poorly correlated
N/A
More